2m 2m 2m 2m 2m 2m 2m
Arbutus Biopharm (ABUS)
NASDAQ
$4.43-$0.13 (-2.85%)
Price as of Oct 02, 2026 5:07 PM EDT- $903.4MMarket Cap
- 1.56%1-Year Change
- BiotechnologyIndustry
Arbutus Biopharm (ABUS)
$4.43-$0.13 (-2.85%)
ABUS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.56 | ||
Change | -$0.22 (-4.60%) | ||
Open | $4.77 | ||
High | $4.78 | ||
Low | $4.51 | ||
Previous Close | $4.78 | ||
Volume | 16,620,397 | ||
30-Day Average Volume | 7,368,826 | ||
1-Week Change | -6.56% | ||
1-Month Change | -10.41% | ||
1-Year Change | 1.56% | ||
3-Year Change | 124.63% | ||
5-Year Change | 6.54% | ||
Fundamentals | |||
Shares Outstanding | 198.1M | ||
Total Assets | $274.0M | ||
Market Cap | $903.4M | ||
Enterprise Value | $884.2M | ||
Period: QTR TTM FY | |||
Revenue | $202,000.00 | ||
Net Income | -$5.1M | ||
Free Cash Flow | -$6.0M | ||
EBIT | -$5.1M | ||
EBITDA | -$5.1M | ||
Net Working Capital | $270.5M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -172 | ||
Enterprise Value/Revenue | 4,377 | ||
P/B | 3 | ||
P/E | -152 | ||
PEG | 1 | ||
Price/Free Cash Flow | -150 | ||
Price/Operating Cash Flow | -150 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue